Incyte to Present at Upcoming Investor Conferences

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences during the month of September:

• Morgan Stanley Global Healthcare Unplugged Conference on Monday, September 13, 2010 at 2:45 p.m. (ET) in New York City;
• Baird 2010 Health Care Conference on Tuesday, September 14, 2010 at 12:45 p.m. (ET) in New York City;
• UBS Global Life Sciences Conference on Monday, September 20, 2010 at 3:00 p.m. (ET) in New York City; and
• Fifth Annual JMP Securities Healthcare Focus Conference on Monday, September 27, 2010 at 12:30 p.m. (ET) in New York City

The presentations will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentations will be available for 30 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. Incyte’s most advanced compound, INCB18424, is in Phase III development for myelofibrosis. For additional information on Incyte, visit the Company's web site at www.incyte.com.